Galinpepimut-S (GPS) is an immunotherapy drug that is now being used to treat mesothelioma. New Phase 1 Clinical Trials are being conducted which use GPS in conjunction with the drug nivolumab (Opdivo®) to treat mesothelioma. The process helps the body’s own immune system recognize the cancer cells and kill them effectively. What is Galinpepimut-S Plus…
Blog
Support Animals for Cancer Patients
Animals such as dogs, cats, and other mammals have been proven to be very beneficial to cancer patients while they are undergoing treatment. Support animals can have physical, mental, and emotional benefits for lung cancer patients. Types of support animals include emotional support animals and service animals. Benefits of Emotional Support Animals for Cancer Patients…
Mesothelioma & Fitness: How to Stay Fit
Staying active and incorporating fitness into your daily routine may help you feel energized and motivated as you battle mesothelioma. Taking a few minutes out of your day to walk, stretch, or practice mindful breathing can have a positive effect on your overall health. Taking care of your overall well-being may help your body react…
Is There Hope For Mesothelioma?
Mesothelioma is an aggressive cancer with a generally poor prognosis. It is very common for patients and their loved ones to lose all hope. However, staying hopeful is known to improve mood, which can have a positive impact on physical health. False hope can be dangerous if it leads to risky treatments without benefits. Staying…
May Is National Cancer Research Month
National Cancer Research Month is celebrated each May and highlights the importance of lifesaving cancer research. Millions of people around the world are deeply affected by cancers such as mesothelioma. Advocating for further research can help us discover a cure for mesothelioma and other cancers. What Is National Cancer Research Month? National Cancer Research Month…
Mesothelioma Gender Analysis
Men account for over 75% of patients diagnosed with mesothelioma due to a greater likelihood of occupational or military exposure to asbestos. This means that little research is done to analyze how mesothelioma affects women. Mesothelioma gender analysis findings indicate that although mesothelioma is more common in the male population, women tend to live longer.…
Recent Study Offers New Hope: PD-L1 Expression in Malignant Peritoneal Mesothelioma
Testing for PD-L1 expression in malignant peritoneal mesothelioma may offer insight into whether patients of this rare cancer are candidates for immunotherapy, such as checkpoint inhibition. Immunotherapy has proven beneficial in other types of mesothelioma. A new study examines it as a possible treatment for peritoneal mesothelioma patients as well. What Is PD-L1…
Women’s History Month: Notable Women in the Mesothelioma World
Women’s History Month was established in 1987 to celebrate and commemorate the contributions and accomplishments of women in history. Remembering the struggles, the sacrifices, and the victories of women in the mesothelioma community is an important part of moving treatment and activism forward. Although mesothelioma is rare in women, they make up an important part…
Lesser-Known Asbestos-Related Diseases: Know Your Risk
Diseases caused by asbestos can be difficult to identify because symptoms may not show up for decades. This means it can be tough to establish a link between exposure and lesser-known asbestos-related diseases. According to the National Cancer Institute (NCI), asbestos-related diseases can be found in individuals with only brief exposure. The best defense is…
